Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2005
10/06/2005US20050221325 Detection of secreted polypeptides
10/06/2005US20050221324 Genotoxicity analysis
10/06/2005US20050221323 Amplification vectors based on trans-splicing
10/06/2005US20050221321 Method of detecting rheumatoid arthritis by detecting overexpression of wnt
10/06/2005US20050221318 Building block forming a c-c bond upon reaction
10/06/2005US20050221316 Method for synthesising templated molecules
10/06/2005US20050221315 Nucleic acid probes, their synthesis and use
10/06/2005US20050221314 Method and device for determination of tissue specificity of free floating dna in bodily fluids
10/06/2005US20050221312 Selective amplification of a template molecule, especially a nucleic acid
10/06/2005US20050221311 Isolated human transporter proteins nucleic acid molecules encoding human transporter proteins and used thereof
10/06/2005US20050221309 Method for the diagnosis of lymphoproliferative diseases
10/06/2005US20050221308 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
10/06/2005US20050221307 Stabilisation of double-stranded nuleic acids using proteins
10/06/2005US20050221306 Detection of predisposition to osteoporosis
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221300 Diagnostic assays for parvovirus B19
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050221293 Isolated nucleic acid molecule comprising the sequence of a DNA virus microRNA; Epstein barr virus; inhibiting microRNP activity in a cell
10/06/2005US20050221292 Vectors with modified protease-dependent tropism
10/06/2005US20050221291 Dc-sign isoforms, related compositions and methods for their use in disease therapy
10/06/2005US20050221290 Identification and validation of novel targets for agrochemicals
10/06/2005US20050221289 Altering viral tropism
10/06/2005US20050221288 Variant tat proteins and methods for use thereof
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050221283 Biochip
10/06/2005US20050221275 Hepatocyte free uptake assays
10/06/2005US20050220965 For low fat spreads; fractionation, interesterification of blends of stearic acid and palmitic acid
10/06/2005US20050220813 Non-spreading pestivirus
10/06/2005US20050220811 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/06/2005US20050220809 Nucleotide sequence coding for a tolc and a defined amino acid sequence
10/06/2005US20050220807 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/06/2005US20050220806 Method of transporting physiological polymer using protein having rxp repeated sequence
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220792 Selective inhibition of NF-kappaB activation by peptides designed to disrupt NEMO oligomerization
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220789 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders
10/06/2005US20050220788 Use of molecules which interact with the haptoglobin receptor ligand binding
10/06/2005US20050220781 IFIX, a novel HIN-200 protein, for cancer therapy
10/06/2005US20050220769 Novel endophytic fungi and methods of use
10/06/2005US20050220768 Materials and methods for treating ocular-related disorders
10/06/2005US20050220767 Production of recombinant respiratory syncytial viruses expressing immune modulatory molecules
10/06/2005US20050220766 Viral vectors and methods for producing and using the same
10/06/2005US20050220765 Viruses with enhanced lytic potency
10/06/2005US20050220757 Chemokine mutants acting as chemokine antagonists
10/06/2005DE10349521A9 Verfahren zur biotechnologischen Herstellung von Alginaten Method for the biotechnological production of alginates
10/06/2005CA2568935A1 Inactive ca2+/calmodulin-dependent protein kinase ii.alpha. knockin animal and knockin cell of the same
10/06/2005CA2563886A1 Compositions and methods for controlling insects related to the octopamine receptor
10/06/2005CA2561696A1 Novel modified galectin 9 proteins and use thereof
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2561377A1 Mussel bioadhesive
10/06/2005CA2561117A1 Decoy nucleic acid to synoviolin gene promoter
10/06/2005CA2560946A1 Compositions for use in identification of viral hemorrhagic fever viruses
10/06/2005CA2560923A1 Annexin ii and uses thereof
10/06/2005CA2560869A1 Treatment of neurodegenerative diseases by the use of laptm4b
10/06/2005CA2560827A1 Preventing arrhythmias associated with cell transplantation
10/06/2005CA2560751A1 Methods for transfecting natural killer cells
10/06/2005CA2560593A1 Exo-endo cellulase fusion protein
10/06/2005CA2560590A1 Modified xylanases exhibiting improved expression
10/06/2005CA2560588A1 Cellulase fusion protein and heterologous cellulase fusion construct encoding the same
10/06/2005CA2560434A1 Plants having increased seed yeild and/or growth rate and method for making same, comprising transformation with a nucleic acid encoding a 40s small subunit ribosomal protein
10/06/2005CA2559867A1 Method for screening agents modulating a lkb$g(a) protein ubiquitination and means for carrying out said method
10/06/2005CA2559541A1 Methods and means for nucleic acid sequencing
10/06/2005CA2557426A1 Rab9a, rab11a, and modulators thereof related to infectious disease
10/05/2005EP1583020A2 Program, method and device for analysis of the time-series data obtained by DNA array method
10/05/2005EP1582597A1 Method of diagnosis of a predisposition to develop thrombotic disease and its uses
10/05/2005EP1582593A2 Apparatus and chip for injecting substance into particle
10/05/2005EP1582592A1 CORN EVENT PV-ZMGT32(NK603) and compositions and methods for dtection thereof
10/05/2005EP1582591A2 Sirna and their use for knock down expression of porcine endogenous retrovirus
10/05/2005EP1582590A1 Sequential intracellular screening method
10/05/2005EP1582589A1 Protein complex, process for producing the same and use thereof
10/05/2005EP1582588A1 PROCESS FOR PRODUCING siRNA
10/05/2005EP1582587A1 Cold-induced expression vector
10/05/2005EP1582584A1 PROCESS FOR PRODUCING PNPase
10/05/2005EP1582583A2 Methods for making plants tolerant to glyphosate and compositions thereof
10/05/2005EP1582582A1 CELL EXTRACT OF i ESCHERICHIA COLI /i HAVING MUTATION IN S12 RIBOSOMAL PROTEIN AND PROCESS FOR PRODUCING PROTEIN IN CELL-FREE SYSTEM USING THE SAME
10/05/2005EP1582529A1 Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA
10/05/2005EP1582255A1 Probe array producing method
10/05/2005EP1582254A1 Member for producing a probe array and probe array producing method
10/05/2005EP1582223A1 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene theraphy
10/05/2005EP1581904A2 Novel proteins with altered immunogenicity
10/05/2005EP1581809A2 Nk cell receptor conjugates for treating malignancies
10/05/2005EP1581791A2 Method for measuring ion channel activity
10/05/2005EP1581656A2 MODULATION OF HIF1a AND HIF2a EXPRESSION
10/05/2005EP1581654A2 Array oligomer synthesis and use
10/05/2005EP1581649A2 Binding agents which inhibit myostatin
10/05/2005EP1581648A2 G protein coupled receptors and uses thereof
10/05/2005EP1581646A2 Extraction of dna from biological samples
10/05/2005EP1581643A2 Plant gene
10/05/2005EP1581642A2 Genes conferring herbicide resistance
10/05/2005EP1581641A2 Compositions, splice variants and methods relating to ovarian specific genes and proteins
10/05/2005EP1581636A2 Methods using gene trapped stem cells for marking pathways of stem cell differentiation and making and isolating differentiated cells
10/05/2005EP1581635A2 Sirna-mediated gene silencing
10/05/2005EP1581633A2 Cloning of cytochrome p450 genes from nicotiana
10/05/2005EP1581632A2 Mutations affecting carotenoid production
10/05/2005EP1581627A2 Yeast protein expression secretion system
10/05/2005EP1581624A2 Eukaryotic genes involved in adult lifespan regulation
10/05/2005EP1581621A2 Novel tumor suppressor gene and compositions and methods for making and using the same
10/05/2005EP1581620A2 Antibodies that recognize hyperproliferative cells and methods of making and using same
10/05/2005EP1581619A2 Polyhydroxyalkanoate production by coenzyme a-dependent aldehyde dehydrogenase pathways
1 ... 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 ... 4023